Tags

Type your tag names separated by a space and hit enter

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
N Engl J Med. 2022 03 17; 386(11):1091-1093.NEJM

Authors+Show Affiliations

Weill Cornell Medicine-Qatar, Doha, Qatar lja2002@qatar-med.cornell.edu.Weill Cornell Medicine-Qatar, Doha, Qatar lja2002@qatar-med.cornell.edu.Ministry of Public Health, Doha, Qatar.No affiliation info available

Pub Type(s)

Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

35081294

Citation

Abu-Raddad, Laith J., et al. "Waning mRNA-1273 Vaccine Effectiveness Against SARS-CoV-2 Infection in Qatar." The New England Journal of Medicine, vol. 386, no. 11, 2022, pp. 1091-1093.
Abu-Raddad LJ, Chemaitelly H, Bertollini R, et al. Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar. N Engl J Med. 2022;386(11):1091-1093.
Abu-Raddad, L. J., Chemaitelly, H., & Bertollini, R. (2022). Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar. The New England Journal of Medicine, 386(11), 1091-1093. https://doi.org/10.1056/NEJMc2119432
Abu-Raddad LJ, et al. Waning mRNA-1273 Vaccine Effectiveness Against SARS-CoV-2 Infection in Qatar. N Engl J Med. 2022 03 17;386(11):1091-1093. PubMed PMID: 35081294.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar. AU - Abu-Raddad,Laith J, AU - Chemaitelly,Hiam, AU - Bertollini,Roberto, AU - ,, Y1 - 2022/01/26/ PY - 2022/1/27/pubmed PY - 2022/3/23/medline PY - 2022/1/26/entrez SP - 1091 EP - 1093 JF - The New England journal of medicine JO - N Engl J Med VL - 386 IS - 11 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/35081294/Waning_mRNA_1273_Vaccine_Effectiveness_against_SARS_CoV_2_Infection_in_Qatar_ DB - PRIME DP - Unbound Medicine ER -